defin
casepati
us
resid
met
clinic
epidemiolog
criteria
suspect
probabl
sar
laboratori
evid
sarscov
infect
laboratori
evid
sarscov
infect
defin
isol
sarscov
detect
sarscov
rna
polymeras
chain
reaction
pcr
detect
antibodi
sarscov
use
enzymelink
immunosorb
assay
indirect
fluorescentantibodi
assay
obtain
verbal
consent
health
offici
use
standard
questionnair
interview
telephon
patient
suspect
probabl
sar
healthcar
provid
data
collect
includ
clinic
symptom
past
medic
histori
relev
exposur
physic
examin
radiograph
laboratori
find
clinic
cours
outcom
casepati
laboratoryconfirm
sar
compar
conveni
sampl
person
met
clinic
epidemiolog
criteria
suspect
probabl
sar
subsequ
test
neg
sarscov
infect
control
neg
find
test
perform
sarscov
includ
absenc
antibodi
viru
convalescentphas
serum
sampl
obtain
day
onset
symptom
statist
analysi
perform
sa
softwar
version
sa
institut
cari
nc
univari
odd
ratio
confid
interv
p
valu
associ
calcul
use
exact
likelihood
method
identifi
casepati
laboratoryconfirm
sarscov
infect
unit
state
date
onset
symptom
februari
may
median
age
casepati
year
rang
year
women
two
casepati
pregnant
week
week
gestat
onset
ill
major
underli
medic
condit
note
seven
casepati
report
travel
area
commun
transmiss
sar
day
ill
onset
includ
hong
kong
n
toronto
n
singapor
n
one
casepati
return
unit
state
day
ill
onset
travel
hong
kong
spous
also
laboratoryconfirm
sar
patient
three
patient
visit
healthcar
facil
travel
day
ill
onset
patient
stay
hotel
associ
welldefin
sar
cluster
cours
ill
find
suggest
lower
respiratori
tract
infect
develop
patient
laboratoryconfirm
sar
find
includ
dyspnea
n
rale
n
hypoxia
n
tabl
symptom
indic
upper
respiratori
tract
infect
includ
rhinorrhea
sore
throat
report
less
often
common
symptom
ill
onset
includ
fever
n
chill
n
headach
n
four
patient
report
least
respiratori
symptom
ill
onset
remain
patient
respiratori
symptom
began
day
ill
onset
median
durat
symptom
patient
sought
medic
evalu
day
rang
day
patient
first
evalu
median
record
temperatur
rang
median
record
oxygen
satur
room
air
rang
gastrointestin
symptom
also
promin
six
patient
report
diarrhea
report
vomit
cours
ill
present
diarrhea
occur
median
day
onset
rang
day
note
n
within
hour
n
receiv
antimicrobi
therapi
vomit
began
median
day
onset
rang
day
casepati
radiograph
evid
pulmonari
infiltr
cours
ill
tabl
bilater
pulmonari
infiltr
develop
patient
cours
ill
interstiti
alveolar
involv
demonstr
worsen
chest
radiograph
find
week
ill
first
abnorm
chest
radiograph
obtain
median
day
onset
symptom
rang
day
six
patient
abnorm
chest
radiograph
first
evalu
includ
bilater
infiltr
two
patient
unremark
initi
chest
radiograph
day
onset
respect
subsequ
note
infiltr
chest
imag
obtain
day
ill
cours
ill
casepati
receiv
antibacteri
therapi
three
patient
also
receiv
oseltamivir
none
treat
ribavirin
one
patient
receiv
corticosteroid
seven
patient
hospit
median
day
rang
day
two
patient
admit
intens
care
unit
day
respect
death
occur
tabl
antibodi
sarscov
develop
patient
posit
pcr
find
clinic
specimen
sputum
stool
specimen
variabl
level
clinic
laboratori
test
perform
tabl
patient
laboratoryconfirm
sar
compar
control
year
old
radiograph
evid
pneumonia
fortyfour
control
test
neg
antibodi
sarscov
serum
obtain
day
symptom
onset
remain
control
neg
serolog
find
sarscov
day
ill
onset
patient
similar
control
regard
age
sex
fiftyeight
control
report
travel
area
commun
transmiss
sar
day
ill
onset
howev
patient
significantli
like
control
visit
healthcar
facil
travel
versu
p
stay
hotel
associ
sar
cluster
versu
p
univari
analysi
clinic
featur
show
dyspnea
hypoxia
rale
vomit
diarrhea
common
among
patient
control
tabl
casepati
also
significantli
like
control
report
fever
initi
symptom
versu
p
abnorm
chest
radiograph
time
first
evalu
versu
p
analysi
limit
patient
radiograph
evid
pneumonia
dyspnea
vomit
remain
associ
sarscov
infect
addit
case
significantli
like
bilater
multifoc
infiltr
case
versu
control
p
radiograph
progress
pulmonari
infiltr
week
ill
case
versu
control
p
compar
us
patient
laboratoryconfirm
sar
control
met
clinic
epidemiolog
criteria
suspect
probabl
sar
find
indic
sarscov
infect
associ
signific
lower
respiratori
tract
diseas
patient
laboratoryconfirm
sar
like
control
dyspnea
hypoxia
rale
patient
also
like
control
abnorm
chest
radiograph
time
first
evalu
clinic
find
similar
report
case
seri
asia
canada
contrast
clinic
manifest
sarscov
viral
respiratori
pathogen
includ
human
coronavirus
compar
control
radiograph
evid
pneumonia
patient
sar
like
manifest
dyspnea
progress
bilater
pulmonari
infiltr
radiograph
progress
multifoc
infiltr
promin
find
sever
previou
studi
may
prove
hallmark
featur
later
stage
diseas
among
us
casepati
diarrhea
vomit
also
significantli
associ
sarscov
infect
gastrointestin
symptom
rel
uncommon
featur
previou
report
diarrhea
frequent
report
case
seri
includ
major
commun
outbreak
hong
kong
apart
block
although
previou
studi
describ
clinic
featur
patient
laboratoryconfirm
sar
none
compar
characterist
patient
control
find
suggest
combin
gastrointestin
symptom
dyspnea
bilater
pulmonari
infiltr
may
warrant
higher
level
suspicion
sarscov
infect
contrast
patient
find
upper
respiratori
tract
infect
may
unlik
sar
although
moder
lymphopenia
promin
among
us
casepati
also
fairli
common
find
among
control
like
viral
sourc
infect
small
number
person
laboratoryconfirm
sar
unit
state
limit
power
identifi
independ
clinic
predictor
sarscov
infect
data
need
describ
full
clinic
spectrum
sarscov
infect
clarifi
specif
clinic
find
like
occur
cours
ill
earli
recognit
possibl
sarscov
infect
rapid
initi
infect
control
precaut
current
import
strategi
control
sar
identifi
person
warrant
investig
sarscov
infect
may
difficult
basi
clinic
symptom
alon
especi
earli
cours
ill
appropri
prepared
sar
thu
requir
vigil
clinician
public
health
offici
integr
time
epidemiolog
inform
astut
clinic
evalu
improv
laboratori
diagnost
tool
